Skip Navigation

Cardiovascular Research 2002 55(3):553-560; doi:10.1016/S0008-6363(02)00283-3
© 2002 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Smith, R. M
Right arrow Articles by Sack, M. N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, R. M
Right arrow Articles by Sack, M. N
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2002, European Society of Cardiology

Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNF{alpha} gene

Robert M Smith, Naushaad Suleman, Joy McCarthy and Michael N Sack*

Hatter Institute for Cardiology Research, MRC Inter-University Cape Heart Group, University of Cape Town Medical School, Observatory 7925, Cape Town, South Africa

* Corresponding author. Tel.: +27-21-406-6350; fax: +27-21-447-8789 sack{at}capeheart.uct.ac.za

Objective: Tumor necrosis factor alpha (TNF{alpha}) is known to mimic ischemic preconditioning (IP). However, it is not known whether TNF{alpha}-preconditioning is mediated by ‘established’ preconditioning signaling or via novel signaling cascades. Moreover, whether TNF{alpha} is required to induce the ischemic preconditioning phenotype has not been determined. Methods: To evaluate the role of TNF{alpha}, we determined the infarct-sparing effect of IP comparing TNF{alpha} null (TNF{alpha}–/–) and wild-type mice. The IP protocol included 4x5 min ischemia/reperfusion (I/R) prior to the index 35 min of global ischemia followed by 45 min of reperfusion in isolated perfused murine hearts. Infarct size was measured as a percentage of cardiac volume. To evoke particular signaling pathways numerous pharmacologic studies were performed. Results: Following IP, infarct size was significantly reduced by 43% in wild-type mice. In contrast, infarct size was not attenuated by IP in the TNF{alpha}–/– group versus I/R controls (Infarct size—36±3%). Interestingly, pharmacologic preconditioning with adenosine (100 µM) and diazoxide (30 µM) mimicked IP in both the wild-type (infarct size—11±4% and 18±2%) and in TNF{alpha}–/– mice (infarct size—15±4% and 23±3%) versus respective I/R controls. Recombinant TNF{alpha} (0.5 ng/ml) administered for 7 min followed by a 10-min washout mimicked IP in wild-type mice but not in the TNF{alpha} deficient mouse hearts. The cardioprotective effects of IP, adenosine and TNF{alpha} were abolished by the co-administration of the putative mitochondrial KATP blocker 5-hydroxydecanoate. Conclusions: We demonstrate that cardiac TNF{alpha} production is required for ischemic preconditioning-induced cardioprotection but not necessary in pharmacologic preconditioning with adenosine or diazoxide in TNF{alpha}–/– mice. Moreover, TNF{alpha} administration is sufficient to activate preconditioning in wild-type mice. Finally, as 5-hydroxydecanoate abrogates ischemic, adenosine and TNF{alpha} induced preconditioning, this suggests that diverse signaling pathways converge at the level of mitochondrial KATP channel activation to mediate this cardioprotection.

KEYWORDS Adenosine; Immunology; Ischemia; K-ATP channel; Preconditioning


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
L. Lacerda, S. Somers, L. H. Opie, and S. Lecour
Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway
Cardiovasc Res, November 1, 2009; 84(2): 201 - 208.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. K. Jones, G.-C. Fan, S. Liao, J.-M. Zhang, Y. Wang, N. L. Weintraub, E. G. Kranias, J. E. Schultz, J. Lorenz, and X. Ren
Peripheral Nociception Associated With Surgical Incision Elicits Remote Nonischemic Cardioprotection Via Neurogenic Activation of Protein Kinase C Signaling
Circulation, September 15, 2009; 120(11_suppl_1): S1 - S9.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Valen
Extracardiac approaches to protecting the heart
Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 651 - 657.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Suleman, S. Somers, R. Smith, L. H. Opie, and S. C. Lecour
Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning
Cardiovasc Res, July 1, 2008; 79(1): 127 - 133.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Skyschally, P. Gres, S. Hoffmann, M. Haude, R. Erbel, R. Schulz, and G. Heusch
Bidirectional Role of Tumor Necrosis Factor-{alpha} in Coronary Microembolization: Progressive Contractile Dysfunction Versus Delayed Protection Against Infarction
Circ. Res., January 5, 2007; 100(1): 140 - 146.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Bellahcene, S. Jacquet, X. B. Cao, M. Tanno, R. S. Haworth, J. Layland, A. M. Kabir, M. Gaestel, R. J. Davis, R. A. Flavell, et al.
Activation of p38 Mitogen-Activated Protein Kinase Contributes to the Early Cardiodepressant Action of Tumor Necrosis Factor
J. Am. Coll. Cardiol., August 1, 2006; 48(3): 545 - 555.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. A. Petersen, K. A. Krumholz, J. Carmen, A. P. Sinai, and B. A. Burleigh
Trypanosoma cruzi Infection and Nuclear Factor Kappa B Activation Prevent Apoptosis in Cardiac Cells
Infect. Immun., March 1, 2006; 74(3): 1580 - 1587.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Lecour, N. Suleman, G. A. Deuchar, S. Somers, L. Lacerda, B. Huisamen, and L. H. Opie
Pharmacological Preconditioning With Tumor Necrosis Factor-{alpha} Activates Signal Transducer and Activator of Transcription-3 at Reperfusion Without Involving Classic Prosurvival Kinases (Akt and Extracellular Signal-Regulated Kinase)
Circulation, December 20, 2005; 112(25): 3911 - 3918.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. A. Petersen, K. A. Krumholz, and B. A. Burleigh
Toll-Like Receptor 2 Regulates Interleukin-1{beta}-Dependent Cardiomyocyte Hypertrophy Triggered by Trypanosoma cruzi
Infect. Immun., October 1, 2005; 73(10): 6974 - 6980.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Zhang, Y.-J. Xu, H. K. Saini, B. Turan, P. P. Liu, and N. S. Dhalla
Pentoxifylline attenuates cardiac dysfunction and reduces TNF-{alpha} level in ischemic-reperfused heart
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H832 - H839.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Lecour, L. Rochette, and L. Opie
Free radicals trigger TNF{alpha}-induced cardioprotection
Cardiovasc Res, January 1, 2005; 65(1): 239 - 243.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Ramani, M. Mathier, P. Wang, G. Gibson, S. Togel, J. Dawson, A. Bauer, S. Alber, S. C. Watkins, C. F. McTiernan, et al.
Inhibition of tumor necrosis factor receptor-1-mediated pathways has beneficial effects in a murine model of postischemic remodeling
Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1369 - H1377.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. M. Smith, N. Suleman, L. Lacerda, L. H. Opie, S. Akira, K. R. Chien, and M. N. Sack
Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning
Cardiovasc Res, September 1, 2004; 63(4): 611 - 616.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
J. M. Edelberg, A. Wong, J. M. Holm, M. Xaymardan, I. Duignan, A. Chin, J. R. Kizer, and D. Cai
Phage display identification of age-associated TNF{alpha}-mediated cardiac oxidative induction
Physiol Genomics, August 11, 2004; 18(3): 255 - 260.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Skyschally, R. Schulz, P. Gres, I. Konietzka, C. Martin, M. Haude, R. Erbel, and G. Heusch
Coronary microembolization does not induce acute preconditioning against infarction in pigs--the role of adenosine
Cardiovasc Res, August 1, 2004; 63(2): 313 - 322.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. M. YELLON and J. M. DOWNEY
Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology
Physiol Rev, October 1, 2003; 83(4): 1113 - 1151.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. J. Duncker, P. D. Verdouw, M. Suzuki, T. Saito, T. Sato, M. Tamagawa, T. Miki, S. Seino, and H. Nakaya
Cardioprotective Effect of Diazoxide Is Mediated by Activation of Sarcolemmal but not Mitochondrial ATP-Sensitive Potassium Channels in Mice * Response
Circulation, August 12, 2003; 108 (6): e44 - e44.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Cai, M. Xaymardan, J. M. Holm, J. Zheng, J. R. Kizer, and J. M. Edelberg
Age-associated impairment in TNF-{alpha} cardioprotection from myocardial infarction
Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H463 - H469.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Belosjorow, I. Bolle, A. Duschin, G. Heusch, and R. Schulz
TNF-alpha antibodies are as effective as ischemic preconditioning in reducing infarct size in rabbits
Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H927 - H930.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Martire, B. Fernandez, A. Buehler, C. Strohm, J. Schaper, R. Zimmermann, P. E Kolattukudy, and W. Schaper
Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice mimics ischemic preconditioning through SAPK/JNK1/2 activation
Cardiovasc Res, February 1, 2003; 57(2): 523 - 534.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. M Yellon and J. M Downey
Spotlight on preconditioning
Cardiovasc Res, August 15, 2002; 55(3): 425 - 428.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.